April 16, 2024
“Vertex Pharmaceuticals VRTX -0.02%decrease; red down pointing triangle has agreed to acquire Alpine Immune Sciences ALPN -0.01%decrease; red down pointing triangle for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up. The companies said Wednesday that Vertex would… Continue Reading…
May 17, 2023
“Pfizer Inc. sold $31 billion of debt in the fourth-largest US bond sale ever, according to a person with knowledge of the matter. The pharmaceutical giant raked in over $85 billion in orders for the eight part investment-grade deal, which… Continue Reading…
October 20, 2020
“Neos Therapeutics (NEOS)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target… Continue Reading…
June 9, 2020
Remember this article I posted. This stock is going to explode. Not only are the rumors there the numbers are, people watching the stock, how it’s preforming is there, I have a good gut feeling about this stock is there.… Continue Reading…
January 24, 2020
“Upon completion of the merger, the Company will change its name to Qualigen, Inc., or a similar name selected by Qualigen… …the pre-merger Ritter Pharmaceuticals stockholders will own approximately 7.5% of the post-merger combined company and the pre-merger Qualigen stockholders… Continue Reading…
Recent Comments